Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Forbion Ventures

Tracked across 4 events · 24 articles · First seen Jul 08, 2026 · Last active Sep 18, 2026

Sentiment
19
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 50
Business
Impact: Forbion Ventures participated in the private placement and will have board representation in the combined company.
Aug 17, 2026 · 6 articles
2 15
Business
Solstice Oncology, a clinical-stage immuno-oncology company focused on neoadjuvant cancer treatment, launched with a $225 million Series A financing led by RA Capital Management, with participation from Canaan Partners, Forbion Ventures and other investors. The…
Impact: Forbion Ventures participated in the Series A financing, adding a differentiated CTLA-4 asset to its portfolio.
Sep 09, 2026 · 6 articles
2 10
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Participated in the oversubscribed private placement financing.
Sep 17, 2026 · 6 articles
1 0
Business
Impact: Patrick Vink is a senior advisor to Forbion Ventures.
Jul 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Forbion Ventures live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.